Pharmaceutical Industry Reports

Reports > Pharmaceutical > Selected Report

Global Flu Vaccine Market Report for Period 2017 to 2022, Market Share, Size, Analysis, Historical Data, Forecast and Manufacturer Profiles

Single User: $2195
Multiple User: $3195
Enterprise User: $4195


Report Summary:

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Scope of the Report
This report focuses on the Flu Vaccine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson Johnson

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines

Market Segment by Applications, can be divided into
For Children (6 months to 3 years)
For Adults and Children over 3 years

There are 15 Chapters to deeply display the global Flu Vaccine market.

Chapter 1, to describe Flu Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force

Chapter 2, to analyze the top manufacturers of Flu Vaccine, with sales, revenue, and price of Flu Vaccine, in 2016 and 2017

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017

Chapter 4, to show the global market by regions, with sales, revenue and market share of Flu Vaccine, for each region, from 2012 to 2017

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017

Chapter 12, Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022

Chapter 13, 14 and 15, to describe Flu Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents

1 Market Overview
1.1 Flu Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Whole Virus Vaccines
1.2.2 Split Virus Vaccines
1.2.3 Subunit Vaccines
1.2.4 Live Attenuated Virus Vaccines
1.3 Market Analysis by Applications
1.3.1 For Children (6 months to 3 years)
1.3.2 For Adults and Children over 3 years
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CSL
2.1.1 Business Overview
2.1.2 Flu Vaccine Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 CSL Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 GSK
2.2.1 Business Overview
2.2.2 Flu Vaccine Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sanofi Pasteur
2.3.1 Business Overview
2.3.2 Flu Vaccine Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Sanofi Pasteur Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Mylan
2.4.1 Business Overview
2.4.2 Flu Vaccine Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Mylan Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Flu Vaccine Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 AstraZeneca Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Flu Vaccine Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Pfizer Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Johnson Johnson
2.7.1 Business Overview
2.7.2 Flu Vaccine Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Johnson Johnson Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Flu Vaccine Market Competition, by Manufacturer
3.1 Global Flu Vaccine Sales and Market Share by Manufacturer
3.2 Global Flu Vaccine Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Flu Vaccine Manufacturer Market Share
3.3.2 Top 6 Flu Vaccine Manufacturer Market Share
3.4 Market Competition Trend
4 Global Flu Vaccine Market Analysis by Regions
4.1 Global Flu Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Flu Vaccine Sales by Regions (2012-2017)
4.1.2 Global Flu Vaccine Revenue by Regions (2012-2017)
4.2 North America Flu Vaccine Sales and Growth (2012-2017)
4.3 Europe Flu Vaccine Sales and Growth (2012-2017)
4.4 Asia-Pacific Flu Vaccine Sales and Growth (2012-2017)
4.5 South America Flu Vaccine Sales and Growth (2012-2017)
4.6 Middle East and Africa Flu Vaccine Sales and Growth (2012-2017)
5 North America Flu Vaccine by Countries
5.1 North America Flu Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Flu Vaccine Sales by Countries (2012-2017)
5.1.2 North America Flu Vaccine Revenue by Countries (2012-2017)
5.2 USA Flu Vaccine Sales and Growth (2012-2017)
5.3 Canada Flu Vaccine Sales and Growth (2012-2017)
5.4 Mexico Flu Vaccine Sales and Growth (2012-2017)
6 Europe Flu Vaccine by Countries
6.1 Europe Flu Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Flu Vaccine Sales by Countries (2012-2017)
6.1.2 Europe Flu Vaccine Revenue by Countries (2012-2017)
6.2 Germany Flu Vaccine Sales and Growth (2012-2017)
6.3 UK Flu Vaccine Sales and Growth (2012-2017)
6.4 France Flu Vaccine Sales and Growth (2012-2017)
6.5 Russia Flu Vaccine Sales and Growth (2012-2017)
6.6 Italy Flu Vaccine Sales and Growth (2012-2017)
7 Asia-Pacific Flu Vaccine by Countries
7.1 Asia-Pacific Flu Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Flu Vaccine Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Flu Vaccine Revenue by Countries (2012-2017)
7.2 China Flu Vaccine Sales and Growth (2012-2017)
7.3 Japan Flu Vaccine Sales and Growth (2012-2017)
7.4 Korea Flu Vaccine Sales and Growth (2012-2017)
7.5 India Flu Vaccine Sales and Growth (2012-2017)
7.6 Southeast Asia Flu Vaccine Sales and Growth (2012-2017)
8 South America Flu Vaccine by Countries
8.1 South America Flu Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Flu Vaccine Sales by Countries (2012-2017)
8.1.2 South America Flu Vaccine Revenue by Countries (2012-2017)
8.2 Brazil Flu Vaccine Sales and Growth (2012-2017)
8.3 Argentina Flu Vaccine Sales and Growth (2012-2017)
8.4 Columbia Flu Vaccine Sales and Growth (2012-2017)
9 Middle East and Africa Flu Vaccine by Countries
9.1 Middle East and Africa Flu Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Flu Vaccine Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Flu Vaccine Revenue by Countries (2012-2017)
9.2 Saudi Arabia Flu Vaccine Sales and Growth (2012-2017)
9.3 UAE Flu Vaccine Sales and Growth (2012-2017)
9.4 Egypt Flu Vaccine Sales and Growth (2012-2017)
9.5 Nigeria Flu Vaccine Sales and Growth (2012-2017)
9.6 South Africa Flu Vaccine Sales and Growth (2012-2017)
10 Global Flu Vaccine Market Segment by Type
10.1 Global Flu Vaccine Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Flu Vaccine Sales and Market Share by Type (2012-2017)
10.1.2 Global Flu Vaccine Revenue and Market Share by Type (2012-2017)
10.2 Whole Virus Vaccines Sales Growth and Price
10.2.1 Global Whole Virus Vaccines Sales Growth (2012-2017)
10.2.2 Global Whole Virus Vaccines Price (2012-2017)
10.3 Split Virus Vaccines Sales Growth and Price
10.3.1 Global Split Virus Vaccines Sales Growth (2012-2017)
10.3.2 Global Split Virus Vaccines Price (2012-2017)
10.4 Subunit Vaccines Sales Growth and Price
10.4.1 Global Subunit Vaccines Sales Growth (2012-2017)
10.4.2 Global Subunit Vaccines Price (2012-2017)
10.5 Live Attenuated Virus Vaccines Sales Growth and Price
10.5.1 Global Live Attenuated Virus Vaccines Sales Growth (2012-2017)
10.5.2 Global Live Attenuated Virus Vaccines Price (2012-2017)
11 Global Flu Vaccine Market Segment by Application
11.1 Global Flu Vaccine Sales Market Share by Application (2012-2017)
11.2 For Children (6 months to 3 years) Sales Growth (2012-2017)
11.3 For Adults and Children over 3 years Sales Growth (2012-2017)
12 Flu Vaccine Market Forecast (2017-2022)
12.1 Global Flu Vaccine Sales, Revenue and Growth Rate (2017-2022)
12.2 Flu Vaccine Market Forecast by Regions (2017-2022)
12.2.1 North America Flu Vaccine Market Forecast (2017-2022)
12.2.2 Europe Flu Vaccine Market Forecast (2017-2022)
12.2.3 Asia-Pacific Flu Vaccine Market Forecast (2017-2022)
12.2.4 South America Flu Vaccine Market Forecast (2017-2022)
12.2.5 Middle East and Africa Flu Vaccine Market Forecast (2017-2022)
12.3 Flu Vaccine Market Forecast by Type (2017-2022)
12.4 Flu Vaccine Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 21780

Category: 16

Published date: 2017-08-29 14:39:51

Number of Pages: 126

Publisher Name: GIR

Over all Rating: 90 % (Average of Ratings provided by clients)